# Native Microbials

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/native-microbials

- Industry: Biotechnology
- Headquarters: San Diego, US
- Website: www.nativemicrobials.com
- Total disclosed funding: $59M
- Latest round: Series B (May 27, 2020)
- Investors on record: 5

## About

Native Microbials, Inc. is a biotechnology company focused on creating innovative microbial solutions to enhance animal health and performance across livestock and companion animals.Founded in 2015 and headquartered in San Diego, US, Native Microbials, Inc. develops specialized microbial products for the animal health sector. The company has completed five investment deals, with the most recent being a Series B funding round in April 2022, led by Temasek Holdings. Founders Karsten Zengler and Mallory Embree, alongside CEO Mike Seely, have leveraged their expertise to drive the company’s growth. Native Microbials has raised a total of USD 46.00 mn, achieving a current valuation of USD 141.06 mn.Native Microbials specializes in developing purpose-built microbial solutions tailored for the animal health industry. Their offerings include innovative microbial formulations designed to enhance the health and performance of livestock and companion animals, utilizing proprietary technology that focuses on improving gut health and optimizing nutrient absorption. The company serves livestock producers, veterinarians, and pet owners across the US, Canada, and select European and Asian markets, addressing challenges in animal health such as digestive disorders and nutritional deficiencies.Native Microbials generates revenue through B2B sales and partnerships with distributors in the animal health sector. Their business model involves bulk purchases or subscription agreements for ongoing supplies, particularly for their flagship products that have demonstrated efficacy in promoting animal health. Pricing plans are tailored to accommodate various customer segments, supporting a steady revenue stream while expanding market reach in the evolving animal health industry.In April 2022, Native Microbials, Inc. raised USD 46.00 mn in a Series B funding round to enhance its manufacturing and supply chain capabilities. The company is focused on expanding its product line with new microbial solutions aimed at improving animal health outcomes. Additionally, they plan to target new geographic markets to broaden their customer base, with specific plans to enter more regions in Europe and Asia by 2024. The recent funding will be instrumental in supporting these expansion initiatives.

## Funding rounds

- Series B, May 27, 2020, $46M — Temasek Holdings, Formation8, Anterra Capital, Cavallo Ventures
- Series A, Apr 11, 2016, $13M — LeFrak

## Investors

- LeFrak (https://capitalatlas.ai/funds/lefrak) — Series A
- Temasek Holdings — Series B
- Formation8 (https://capitalatlas.ai/funds/formation8) — Series B
- Anterra Capital (https://capitalatlas.ai/funds/anterra-capital) — Series B
- Cavallo Ventures (https://capitalatlas.ai/funds/cavallo-ventures) — Series B